Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Publication | Open Access

DOI Full Paper Access

Citations

References

2010

Year

Hiroyuki Nomura, Daisuke Aoki, Fumiaki Takahashi, Noriyuki Katsumata, Yoh Watanabe, Ikuo Konishi, Toshiko Jobo, Masayuki Hatae, Masamichi Hiura, Nobuo Yaegashi

Annals of Oncology

MedicineGynecologyPhase Ii StudyCancer TreatmentOncologyRadiation OncologyRecurrent Endometrial CarcinomaGynecology OncologyMolecular OncologyEndocrine-related Cancer